The UK’s withdrawal from the European Union has meant the pharmaceutical industry has had to adapt to some monumental changes in terms of research, regulatory affairs, and trade.
Drug repurposing can shorten drug development timelines via regulatory pathways which expedite the approval process because they avoid duplication of studies previously performed on the drug, according to experts speaking at the CPhI Discover webinar, Dru